ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Tailoring the Porosity of Mesoporous Polyphenol Nanoparticles for Enhanced Photothermal Antibacterial Therapy.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A biomimetic urchin-like photothermal nanoplatform for the efficient eradication ofFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Photothermal therapy offers a promising alternative for treating infected wounds while mitigating antibiotic overuse. However, the limited near-infrared (NIR) photothermal conversion efficiency of polymeric materials hinders their clinical translation. Herein, we report the synthesis of Mn-chelated mesoporous poly(L-DOPA) nanoparticles (Mn-mDOPA) via polymerization-induced self-assembly, where the surfactant/oil ratio and Mn loading are precisely tuned to optimize mesoporosity and photothermal performance. The resulting Mn-mDOPA nanoparticles exhibit enlarged mesopores (≈28-39 nm) and a high specific surface area (up to 75.4 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.